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Abstract 
Background 
Airways progenitors may be involved in embryogenesis and lung repair. The characterization 
of these important populations may enable development of new therapeutics to treat acute or 
chronic lung disease. In this study, we aimed to establish the presence of bronchioloalveolar 
progenitors in ovine lungs and to characterize their potential to differentiate into specialized 
cells. 
Results 
Lung cells were studied using immunohistochemistry on frozen sections of the lung. 
Immunocytochemistry and flow cytometry were conducted on ex-vivo derived pulmonary 
cells. The bronchioloalveolar progenitors were identified by their co-expression of CCSP, 
SP-C and CD34. A minor population of CD34pos/SP-Cpos/CCSPpos cells (0.33% ± 0.31) was 
present ex vivo in cell suspensions from dissociated lungs. Using CD34 magnetic positive-
cell sorting, undifferentiated SP-Cpos/CCSPpos cells were purified (>80%) and maintained in 
culture. Using synthetic media and various extracellular matrices, SP-Cpos/CCSPpos cells 
differentiated into either club cells (formerly named Clara cells) or alveolar epithelial type-II 
cells. Furthermore, these ex vivo and in vitro derived bronchioloalveolar progenitors 
expressed NANOG, OCT4 and BMI1, specifically described in progenitors or stem cells, and 
during lung development. 
Conclusions 
We report for the first time in a large animal the existence of bronchioloalveolar progenitors 
with dual differentiation potential and the expression of specialized genes. These newly 
described cell population in sheep could be implicated in regeneration of the lung following 
lesions or in development of diseases such as cancers. 
Keywords 
Lung, Progenitor, Bronchioloalveolar, SP-C, CCSP, CD34, Sheep, Differentiation, 
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Background 
It is now established that post-natal and adult lungs contain multiple progenitors or stem cell 
populations able to participate to organ homeostasis and repair [1]. The relative distribution 
of these populations varies between species [2,3] and these cells are difficult to evidence as 
the consequence of the low turn-over of the respiratory epithelium [4]. The mouse system 
allowing the study of cell regeneration in response to chemical injury and more recently in 
vivo genetic lineage tracing [5,6] has supplied a model to explore and describe epithelial 
lineages implicated in lung repair. Even so the murine pulmonary epithelium is rather 
different from the ones of the large mammals. In small mammals such as rodents, the 
proximal airways are composed of a layer comprising one or two cells thick that rests on a 
very sparse network of basal cells [7-10]. In large mammals, this epithelium is characterized 
by pseudo-stratified columnar cells together with ciliated, secretory, and parabasal cells 
linked to a foundation of basal cells [11,12]. Moreover club cells, formerly named Clara cells 
[13-15] are present throughout the mouse airways while confined to the most distal 
bronchiolar airways in humans. Regeneration of alveolar tissue is rapid and efficient in 
rodents, but takes longer and needs higher level of stimulation in large mammals [16]. Taking 
in account these observed differences on composition and temporal dynamics, the description 
of the resident progenitor populations is of importance in large mammals to better understand 
the building, maintenance and repair of the lung epithelium. Moreover, sheep have a long 
history as an experimental model to study respiratory diseases. These small ruminants have 
been proposed as good candidates for vaccine development as well as for comprehensive 
studies on asthma, bronchial obstruction or infant respiratory distress syndrome. It also 
provides a very useful model for respiratory infections and lung cancer. 
Cystic fibrosis, chronic obstructive pulmonary disease and lung adenocarcinoma are part of 
the lung diseases that affect the distal lung and could appeal for progenitor or stem cell 
activation. The bronchioloalveolar region has been extensively studied in normal and injured 
lungs of rats and mice in response to chemical treatments. Undifferentiated cells in the 
bronchioloalveolar duct junction have been histologically identified as different from the 
alveolar epithelial type II cells (AECII), the club cells (Clara) or the ciliated cells [17]. In 
mice, these bronchioloalveolar progenitors, referred as BASCs (BronchioloAlveolar Stem 
Cells), share phenotypic characteristics of both club cells and AECIIs, suggesting a niche of 
progenitors [2,17-20]. They express both CCSP (Club Cell Secretory Protein specific of the 
club cells), SP-C (Surfactant Protein C), a component of the pulmonary surfactant produced 
by the AECII and CD34, a surface antigen of the hematopoietic stem cells [18,21]. Murine 
BASCs appear to be resistant to bronchiolar and alveolar damage in vivo, proliferate during 
epithelial repair and have the potential to give rise to club cells and AECIs or AECIIs [18,21]. 
Whether analogous pulmonary epithelial progenitors are present and could differentiate into 
specialized bronchiolar or alveolar cells in large animals is currently unknown. 
We looked for bronchioloalveolar progenitors in sheep by ex vivo isolation of CD34pos/SP-
Cpos/CCSPpos cells. Using CD34-magnetic positive cell selection, we isolated a SP-
Cpos/CCSPpos viable cell population from the lungs of 0 to 3 month old lambs. Synthetic 
media and various extracellular matrix were used to establish the in vitro conditions to 
maintain SP-Cpos/CCSPpos cells in an undifferentiated and proliferative state or, alternatively, 
to induce their differentiation into either club cells or AECIIs. The bronchioloalveolar 
progenitors obtained ex vivo or maintained in vitro were further shown to express genes 
involved in stem cells or lung development such as NANOG (Nanog homeobox), OCT4 
(Octamer-binding transcription factor 4) and BMI1 (polycomb ring finger oncogene). The 
expression of these genes was modulated upon exposure to culture conditions favoring cell 
differentiation. 
Results 
In vivo description of SP-Cpos, CCSPpos and SP-Cpos/CCSPpos pulmonary cells 
The expression of SP-C and CCSP was analyzed in the lungs of 0 to 3 month old lambs by 
immunohistochemistry on frozen sections using cross-reacting antibodies. As expected, these 
antibodies specifically recognized cells expressing SP-C in the alveoli and cells expressing 
CCSP in the bronchioli (Figure 1A) validating their use as specific markers of respectively 
AECIIs and club cells in sheep. AECIIs were easily detectable in most of the sections due to 
their high expression of SP-C (Figure 1B) and club cells expressing CCSP were detectable 
when bronchioli were present on the lung section. Interestingly, rare SP-Cpos/CCSPpos cells 
were observed in some lung sections (Figure 1B), demonstrating the presence of 
bronchioloalveolar progenitors in newborn lambs. Among the 4 independent lungs and 
repeated immuno-stainings, the SP-Cpos/CCSPpos cells remained rare and only present on few 
lung sections. But this first in vivo evidence for the presence of progenitor-like pulmonary 
cells prompted us to search for these rare cells among cells obtained from lung dissociation. 
Figure 1 In vivo localization of SP-Cpos/CCSPpos cells. Frozen lung sections from ten 0 to 3 
month old lambs were analyzed by immunohistochemistry for the expression of SP-C 
(green), CCSP (red) and the co-expression of SP-C and CCSP. The nuclei were stained with 
DAPI (blue). (A) Lung cross sections showed the expression of CCSP in the bronchiole (b) 
and SP-C in the alveoli (a) (100x magnification). (B) Immunostaining of rare SP-
Cpos/CCSPpos cells in situ (400x magnification). Inset: enlargement of a SP-C/CCSP double-
positive cell. (C) SP-C and CCSP expression from a representative lamb (# 1507) in ex vivo 
dissociated cells by flow cytometry showing the presence of a SP-Cpos/CCSPpos population. 
(D) Frequency of SP-Cpos, CCSPpos and SP-Cpos/CCSPpos cells from ten 0 to 3 month old 
lambs. The data are expressed as the mean (± SD) percentage of the cells expressing the 
cellular markers. 
To quantify the respective frequency of AECIIs, club cells and progenitors, cell suspensions 
obtained by enzymatic dissociation of lung tissue from 10 lambs (0 to 3 month old) were 
analyzed for their expression of SP-C and CCSP by flow cytometry. Based on the dot plot 
analysis from a representative lamb (Figure 1C) and the compiled data from 10 lambs (Figure 
1D), the suspensions of lung cells repeatedly contained 40% (± 18.5) SP-Cpos cells and 0.65% 
(± 0.60) CCSPpos cells (Figure 1D). Co-expression of SP-C/CCSP was then analyzed to 
quantify the bronchioloalveolar progenitors. An average of 0.33% (± 0.31) of the total cells 
co-expressed the two markers and presented an immunophenotype compatible with lung 
progenitors (Figure 1D). We noted the low percentage of club cells in the cell suspensions 
issued from tissue dissociation. This may be attributed to our tissue processing. In order to 
work mainly with the cell populations present into the lung parenchyma, we carefully have 
macro-dissected the lung tissues before enzymatic digestion in order to limit cells coming 
from the bronchi and bronchioli. Moreover, the number of club cells in the lung of large 
mammals is lower compared to rodents. 
In vitro expansion and phenotypic characterization of primary airway 
epithelial cells 
Dissociated cells were grown in culture with selective Quantum286 synthetic medium 
complemented with KGF and HGF (referred to "complete Q286 medium") on fibronectin-
coated plates and maintained for two to three passages as previously described [22]. Small 
and large cubical epithelial cell colonies and a few spindle-shaped cells were rapidly 
observed after 3 days of culture; the small cubical cells proliferated and were further 
characterized for the expression of SP-C and CCSP. As shown by specific labeling in 
immunocytochemistry and flow cytometry, a majority of the observed cubical cells were SP-
Cpos AECIIs, while few of them were CCSPpos club cells (Figure 2A and 2B). Interestingly, a 
minor population of SP-Cpos/CCSPpos cells, compatible with bronchioloalveolar progenitors, 
was reproducibly identified in culture (Figure 2A and 2B). Compared to the AECIIs, the SP-
Cpos/CCSPpos cells were semi-adherent round cells with small cytoplasmic extensions (Figure 
2A). These double positive SP-Cpos/CCSPpos cells were rare after lung dissociation but 
enriched and maintained upon in vitro culture with synthetic medium (Figure 2B). 
Figure 2 In vitro expansion of SP-Cpos/CCSPpos progenitors. Pulmonary epithelial cells 
from dissociated lung tissues were cultured in vitro on fibronectin-coated plates 
supplemented with "complete Q286 medium". (A) Lung epithelial cells derived from lamb 
#1487 and maintained for 2 passages, were analyzed by immunostaining for the expression of 
SP-C (green), CCSP (red) and the co-expression of SP-C and CCSP (400x magnification). 
Inset: enlargement of double-positive cells. (B) Flow cytometry analysis of a representative 
animal shows the percentage of SP-Cpos cells and CCSPpos cells above the background 
fluorescence. The double staining shows an enriched culture of AECIIs with the presence of 
SP-Cpos/CCSPpos bronchioloalveolar progenitors after dissociation, and at the first and second 
passage in vitro. For each condition, the left graph (smaller) corresponds to controls and the 
right graph (larger) presents SP-C and CCSP specific immunostaining. 
CD34 selection of bronchioloalveolar progenitors 
To isolate and enrich a viable population of bronchioloalveolar progenitors, cells from ex vivo 
dissociated lungs were positively selected using anti-CD34 antibody-coated magnetic beads 
without any prior cell culture step. Cell surface expression of CD34, a surface protein 
expressed by some progenitors or stem cells, was then measured by flow cytometry to assess 
the enrichment of the bronchioloalveolar progenitor population in the selected population. In 
the 6 tested lambs, the CD34 cell sorting remarkably enriched the CD34pos population from 
0.7% (± 0.12) after tissue dissociation to over 90% in the CD34-selected single cell 
suspension (Figure 3) with greater than 85% viability, as measured by trypan blue exclusion. 
Figure 3 Enrichment in CD34pos cells by magnetic cell sorting. Lung primary cells from 
lamb lungs were subjected to magnetic cell sorting with anti-ovine CD34, then analyzed by 
flow cytometry. A: Representative dot plot from one animal showing expression of CD34pos 
cells in the dissociated tissue (Before sorting) and after the positive selection (After sorting) 
B: Enrichment of CD34pos cells from independent magnetic cell sorting from 6 lambs shown 
as the mean(± SD). **: p < 0.01. 
Expression of SP-C and CCSP among the CD34pos-selected population 
To quantify the bronchioloalveolar progenitors among the CD34pos population, the selected 
cells were analyzed for the expression of CCSP and SP-C. By flow cytometry, the majority 
(over 80%) of the CD34pos cells co-expressed CCSP and SP-C with respectively 88% (± 6.8) 
and 84% (± 5.5) positive cells (Figure 4A and 4B). We assumed that hematopoietic stem cells 
or endothelial progenitors may contribute to the SP-Cneg and CCSPneg cells among the 
CD34pos population. Due to the nature of the antibodies used (i.e., polyclonal rabbit anti-
proSP-C, mouse monoclonal or polyclonal rabbit anti-CCSP and monoclonal mouse anti-
CD34), direct double labeling of SP-C and CCSP on the CD34pos population was not 
technically achievable. However, the large proportion of SP-Cpos/CD34pos and 
CCSPpos/CD34pos cells clearly demonstrated that most of the CD34pos cells were SP-
Cpos/CCSPpos progenitors. The proportion of SP-Cpos/CCSPpos cells among the CD34pos 
population was similar in the 6 lambs analyzed independently (Figure 4B). Importantly, the 
proportion of CD34neg/SP-Cpos and CD34neg/CCSPpos cells was very low to undetectable in 
the CD34-sorted cell suspension (1.0% ± 1.7 and 1.1% ± 1.8, respectively), confirming that 
the procedure efficiently purified CD34pos cells and not AECIIs or club cells. Taken together, 
our results suggested that a bronchioloalveolar progenitor population exists in lambs and that 
these cells concomitantly express CD34, SP-C and CCSP. 
Figure 4 Expression of SP-C and CCSP in CD34pos-sorted cells. (A) Dot blot analysis 
from a representative animal (lamb #1744) showing the expression of SP-C and CCSP in the 
majority (>90%) of the CD34pos cells. (B) Combined results from 10 lambs showing the 
enrichment of SP-Cpos/CCSPpos cells in the CD34-selected cell fraction. The data are shown 
as the mean(± SD). **: p < 0.01. Before: before CD34 sorting; After: after CD34 sorting. (C) 
Expression of SP-C, CCSP, CD34, BMI1, OCT4, NANOG and GAPDH mRNAs in the 
unselected and in the CD34-selected cells measured by RT-PCR. 
To further characterize the CD34pos selected population, the mRNA expression of genes 
known to be preferentially but not exclusively expressed in stem cells, such as the self-
renewal factor gene BMI1 and the pluripotent state-specific transcription factor genes OCT4 
and NANOG, were analyzed. The expression of the housekeeping gene GAPDH was analyzed 
as a reference gene. Compared to the total cell suspensions obtained after lung dissociation, 
the CD34pos population expressed higher levels of BMI1, OCT4 and NANOG, suggesting the 
enrichment of progenitors during the purification process (Figure 4C). Interestingly, NANOG 
was almost absent from the unsorted population but was strongly expressed in the CD34pos-
sorted cells (Figure 4C). Importantly, the expression of SP-C, CCSP and CD34 was 
maintained after CD34 selection (Figure 4C). Unfortunately the low number of cells obtained 
during the selection process did not allow us to further quantify the level of gene expression, 
due to the very low amounts of total RNA per analyzed sample. 
In vitro maintenance of the ovine bronchioloalveolar progenitors 
To assess their ability to proliferate in vitro, selected CD34pos progenitors were seeded onto 
inserts (membrane with 0.4 µm pore size) coated with fibronectin and type I and IV collagens 
and cultured with "complete Q286 medium" under “maintenance conditions" (Figure 5A, 5B 
and 5C). After 15 days, these CD34pos cells gave rise to small colonies of cubical epithelial 
cells, most of which expressed SP-C and CCSP (Figure 5A). The majority of these cells 
(>90%) maintained the co-expression of SP-C and CCSP for up to 3 passages (corresponding 
to approximately 45 days in culture) (Figure 5B and 5C). When maintenance conditions were 
applied to cells from 6 independent animals, the same proportions of SP-Cpos/CCSPpos cells 
were generated, and this population of bronchiololaveolar progenitors was maintained over 
time (Figure 5C). While SP-C and CCSP expression persisted, the overall fluorescence 
intensity of these two markers decreased over time to reach a lower but easily detectable 
signal after 3 passages. 
Figure 5 In vitro maintenance and differentiation of bronchioloalveolar progenitors. 
CD34pos/SP-Cpos/CCSPpos cells from explanted lungs were maintained either in a. 
“maintenance conditions” with "complete Q286 medium" on fibronectin and collagen-coated 
inserts, b. differentiated in “AECII conditions” with "complete Q286 medium" on fibronectin 
and collagen-coated plates or c. in “Club conditions” with "basic Q286 medium" on 
fibronectin-coated plates. (A) Representative immunostaining from cells isolated from one 
lamb for SP-C (green) and CCSP (red). Co-expression was performed on in vitro maintained 
bronchioloalveolar progenitors (SP-Cpos/CCSPpos) or differentiated AECIIs (SP-
Cpos/CCSPneg) or club cells (SP-Cneg/CCSPpos). (B) The population of CD34pos/SP-
Cpos/CCSPpos cells from a representative lamb grown in maintenance or differentiation media 
was quantified by flow cytometry for the expression of SP-C or CCSP. The results are 
presented as dot plots of the expression of both markers. (C) CD34pos/SP-Cpos/CCSPpos cells 
from 6 independent lambs cultured in maintenance or differentiation media were followed 
over three passages (p0 to p3) by flow cytometry for the expression of SP-C and CCSP. The 
results are presented as the mean ± SD of the cells expressing each phenotype. 
From bronchioloalveolar progenitors to differentiated epithelial pulmonary 
cells in vitro 
In addition to their self-renewing properties, progenitors must be able to differentiate into 
multiple cell types under specific conditions. Indeed, using synthetic medium and adapted 
cell culture conditions, CD34pos/SP-Cpos/CCSPpos bronchioloalveolar progenitors had the 
potential to differentiate into either AECIIs or club cells. To induce the differentiation of SP-
Cpos/CCSPpos cells into AECIIs, CD34pos cells were seeded onto plates coated with 
fibronectin and type I and IV collagens and cultured with "complete Q286 medium", culture 
conditions that we defined as "AECII conditions". Along 3 passages (approximately 45 days), 
we observed a noticeable increase of the proportion of cell expressing SP-Cpos/CCSPneg 
(Figure 5A and B), whereas the SP-Cpos/CCSPpos population decreased over time (Figure 5C). 
Cultures from 6 independent animals showed the same modulation with an increasing 
proportion of SP-Cpos/CCSPneg AECIIs (from < 5% to 58%; Figure 5C). In contrast, the 
population of SP-Cpos/CCSPpos progenitors rapidly decreased throughout the passages from 
over 90% to less than 30% (Figure 5C). Under these conditions, no CCSPpos cells emerged 
from the initial SP-Cpos/CCSPpos population. Because we have previously shown that none to 
less than 1% (± 1.7) of the CD34neg/SP-Cpos AECII were present after CD34 positive 
selection, our findings strongly argue for the in vitro differentiation of bronchioloalveolar 
progenitors into AECIIs and not the mere proliferation of pre-existing AECIIs. 
Conversely, CD34pos progenitors cultured in "basic Q286 medium" (without KGF and HGF) 
on fibronectin-coated plates, conditions that we defined as "club cell conditions" gave rise to 
colonies containing primarily SP-Cneg/CCSPpos cells (53.6% ± 13) after 15 days in culture 
(Figure 5A, 5B and 5C). Concurrently, SP-Cpos/CCSPpos bronchioloalveolar progenitors 
(24.9% ± 14) rapidly decreased, while SP-Cpos/CCSPneg AECIIs remained low to 
undetectable (5% ± 8; Figure 5C). Similarly to the AECII conditions, we have previously 
shown that none to less than 1.1 (± 1.8%) of the CD34neg/CCSPpos club cells were present 
after CD34 positive selection from the 6 tested lambs, strongly suggesting the in vitro 
differentiation of bronchioloalveolar progenitors into club cells. Together with the low 
proliferation rate of CCSPpos cells in the cultures, our findings strongly argue for the 
differentiation of bronchioloalveolar progenitors into club cells rather than the proliferation 
of already existing club cells in the cultures. 
Expression of NANOG, OCT4 and BMI1 
As previously mentioned, the expression of NANOG and OCT4 is a strong indicator of a stem 
cell/ progenitor phenotype. NANOG and OCT4 were expressed in the CD34pos/SP-
Cpos/CCSPpos cells enriched from dissociated tissues (Figure 4C). To further characterize the 
CD34pos cells that were maintained in vitro and differentiated, RT-PCR was used to analyze 
the expression of OCT4, NANOG and BMI1 in the progenitors maintained in culture and in 
the different enriched, but not pure, cultures of AECIIs and club cells derived from 3 lambs 
(#1729, #1730, #1731) at passage 1 (Figure 6A). BMI1 was expressed at various levels and 
predominantly in the medium that favored the differentiation of bronchioloalveolar 
progenitors into AECIIs (Figure 6B). Importantly, this first passage still contained SP-
Cpos/CCSPpos progenitors. Interestingly, OCT4 was expressed in the “maintenance 
conditions” that favored expansion of bronchioloalveolar progenitors, in which greater than 
70% of the cells displayed a SP-Cpos/CCSPpos phenotype. In the differentiation conditions that 
generated AECIIs or club cells, OCT4 expression was strongly reduced in 2 of the 3 lambs. 
However, in lamb #1730, some expression of OCT4 was detectable in cells cultured in 
“AECII conditions”, which is compatible with the lower proportion of SP-Cpos/CCSPneg 
AECIIs compared to the 2 others lambs at passage 1 (Figure 6A). This result suggests that 
OCT-4 expression was characteristic of cell progenitors and that its expression was lost upon 
differentiation. Surprisingly, the expression of NANOG appeared to be less stable in the 
bronchioloalveolar progenitors maintained in vitro (Figure 6) compared to the ones obtained 
ex vivo, as previously described (Figure 4C), suggesting that the cultured SP-Cpos/CCSPpos 
cells rapidly underwent a differentiation step. 
Figure 6 BMI1 and OCT4 mRNA expression in maintained and differentiated 
CD34pos/SP-Cpos/CCSPpos cells. (A) Depending on the culture medium conditions 
(maintenance, AECII or club medium), the relative proportions of SP-Cpos/CCSPpos, SP-
Cpos/CCSPneg or SP-Cneg/CCSPpos were determined at the first passage by flow cytometry and 
reported in the table as the following: 0% for no cells, + for <15%, ++ ≥15% and ≤50%, and 
+++ for ≥50%. (B) The BMI1, OCT4 and NANOG mRNAs were detected by RT-PCR from 
the total cell RNAs extracted from the three culture conditions at passage 1 and compared to 
the ovine GAPDH housekeeping gene. Prog: progenitors. 
Discussion 
In this study, we described the presence of SP-Cpos/CCSPpos progenitors in the lung 
parenchyma of 0-3 month-old lambs. These rare cells (~0.3% of the pulmonary epithelial 
cells) have been isolated after tissue dissociation and they co-expressed CD34, SP-C and 
CCSP. The SP-Cpos/CCSPpos cells were maintained in vitro for up to 2 or 3 passages (30-45 
days). Pluripotent progenitors are defined by their ability to maintain and differentiate upon 
exposure to specific stimuli. To further characterize the ovine SP-Cpos/CCSPpos cells, we first 
performed positive selection for CD34 expression, a surface protein widely described on 
various stem cells and present on ovine hematopoietic stem/progenitor cells [23]. A small 
population of cells (few thousand) was isolated and characterized as SP-Cpos/CCSPpos cells. 
They expressed mRNAs for the NANOG, OCT4 and BMI1 genes which are molecular 
markers of stem cells/progenitors. They retained the expression of SP-C, CCSP and CD34 
mRNAs over time. Importantly, the CD34pos/SP-Cpos/CCSPpos cells were able to maintain for 
up to 3 passages in vitro. The CD34pos/SP-Cpos/CCSPpos cell population retained the potential 
to differentiate at least into AECIIs or club cells in specific culture conditions. The 
CD34pos/SP-Cpos/CCSPpos cells, maintained in vitro, expressed OCT4 and BMI1 mRNAs, 
conferring them characteristics inherent to multipotent cells or progenitors. 
Bronchioloalveolar progenitors have been reported in mice in an anatomically well-defined 
location at the bronchioloalveolar junction where conducting and respiratory airways meet 
[18,24,25]. These cells were initially described by their expression of Sca-1 and CD34, and 
their co-expression of SP-C and CCSP. We succeeded in demonstrating the in vivo presence 
of rare ovine bronchioloalveolar progenitors in the lungs of newborn or young animals (less 
than 3 months old), while other groups have difficulties to identify bronchioloalveolar 
progenitors in sheep upon searching for these cells using CCSP and SP-C immunostaining on 
lung sections [26,27]. Interestingly, two studies have reported rare to extremely rare SP-
Cpos/CCSPpos cells in virally-induced lung tumors in sheep [26,28]. Taken together, these 
results are consistent with the presence of SP-Cpos/CCSPpos cell population, extremely rare in 
vivo on frozen lung sections and representing a new progenitor population. The discrepancy 
between our study and previous studies [26,27] may be explained by the low but clearly 
above background levels of SP-C and CCSP expression in double-positive cells compared to 
the expression of these markers in AECIIs and club cells, respectively. Moreover, a recent 
study on ovine lung sections, have shown that CCSPpos cells were not (preterm lung) or 
poorly (9 days old lung) detectable in prenatal and early postnatal lung compared to mature 
lung (91 days) in bronchi, terminal bronchioles and respiratory bronchiole [29]. These 
elements point the influence of the age of the lung studied, in the search for postnatal 
bronchioloalveolar CCSPpos/SP-Cpos progenitors. 
The visualization of double-positive cells in the complex lung is therefore challenging and 
the CD34 enrichment strategy enabled us to evidence and to study this progenitor population. 
In addition, bronchioloalveolar progenitors may be more easily identified in lungs from 
newborn lambs. Of note, we have previously reported the presence of SP-Cpos/CCSPpos cells 
in the sheep lung while describing the ex vivo isolation of tumoral AECIIs from a virus-
induced lepidic lung adenocarcinoma [22]. While culturing these cells in three-dimensional 
conditions, better adapted to these polarized and specialized cells, we repeatedly observed 
SP-Cpos/CCSPpos double-positive cells (data not shown). These results prompted us to go 
further into their characterization. 
SP-Cpos/CCSPpos double-positive bronchioloalveolar progenitors are rare and represent less 
than 0.4% of the total epithelial cells from dissociated lungs. In comparison, a recent study 
has established that undifferentiated human stem cells identified by c-kit immunosorting are 
present at a frequency of 1 per 6,000 cells in the bronchioles and 1 per 30,000 cells in the 
alveoli in adults [30]. In fetal human lung tissue at 12-36 weeks of gestation, the frequency of 
stem cells varies from 1 per 11,000 to 1 per 600 cells, with an average of 1 per 4,100 cells 
[30]. Our CD34-positive selection procedure was crucial to isolate bronchioloalveolar 
progenitors from the lung even though the absolute number of CD34pos/SP-Cpos/CCSPpos cells 
was ultimately low (only a few thousands cells) and confirmed the existence of a rare 
population of SP-Cpos/CCSPpos bronchioloalveolar progenitors. Importantly, all of the 
selection steps were performed ex vivo, without any cell culture steps and in the absence of 
fetal calf serum known to induce cell differentiation. 
The CD34pos/SP-Cpos/CCSPpos population resembles the now well-characterized murine 
bronchioloalveolar stem cells in terms of both morphology and cell markers [18,24,25]. We 
clearly demonstrated that ovine bronchioloalveolar progenitors behave as multipotent 
precursors in culture and have maintenance and differentiation potential upon modulation of 
the culture conditions. 
We then demonstrated that the ex vivo-derived ovine bronchioloalveolar progenitors retained 
the expression of the BMI1, OCT4 and NANOG genes which are some of the most important 
markers of undifferentiated pluripotent cells and are major players in embryonic and adult 
stem cells. BMI1 is a member of the PcG family of transcription repressors that play crucial 
roles in development, stem cell biology and cancer [31]. BMI1 is also highly expressed in 
tumors and regulates the cell fate of cancer cells and normal and tumoral stem cells [32,33]. 
BMI1 participates in the maintenance of endogenous stem cells, partly by repressing genes 
involved in cell death and senescence [34]. In mice, BMI1 is necessary for bronchioloalveolar 
stem cells expansion [35]. Similarly to murine bronchioloalveolar stem cells, ovine 
bronchioloalveolar progenitors expressed BMI1 under maintenance/self-renewing conditions, 
and this expression was not modified by exposure to differentiation conditions. 
While OCT4, a member of the POU (Pit-Oct-Unc) transcription factor family, is essential for 
the maintenance of self-renewal capacities, NANOG (a downstream target of OCT4) 
contributes to the cell fate determination of pluripotent cells during embryogenesis [36,37]. 
OCT4 and NANOG are among the few key factors that enable the reprogramming of adult 
somatic cells into pluripotent stem cells [38-42]. Interestingly, induced pluripotent cells 
(iPSCs) generated from sheep fibroblasts have recently been demonstrated to exhibit an 
embryonic stem cell-like morphology and to express OCT4 and NANOG among other 
intracellular and surface markers associated with undifferentiated cells, as previously 
demonstrated in humans and mice [43]. The level of OCT4 is critical for the state of a cell 
and its inactivation results in the loss of pluripotency and induces differentiation [44]. We 
could observe a loss or reduction of OCT4 gene expression in AECII and club cells compared 
to progenitors. OCT4 and NANOG are expressed in lung stem cells, and their co-expression 
may enhance malignancy by inducing cancer stem cell-like properties [45,46]. Surprisingly, 
NANOG gene expression was higher in AECII and club cells than in progenitors in our in 
vitro culture conditions. NANOG expression is known to be regulated by a number of 
pluripotent transcription factors (FoxD3, SOX2, OCT4) [47]. It is likely that this complex 
regulation is also dependent of the in vitro context (growth factors, monolayer or 2D culture 
conditions) and others active signaling cascades [48]. With respect to the recently described 
human c-kit lung stem cell [30], it would be interesting to study the expression of c-kit in 
lamb lung sections and in the SP-Cpos/CCSPpos bronchioloalveolar progenitors population to 
better understand the hierarchical organization of these progenitors in this complex tissue. 
Conclusions 
We report here the first direct characterization of CD34pos/SP-Cpos/CCSPpos 
bronchioloalveolar progenitors from the lung of a large animal. While extremely rare, these 
cells can be purified and enriched from the lungs of newborn lambs. These cells have a 
potential to maintain and differentiate in highly specialized epithelial cells. The SP-
Cpos/CCSPpos bronchioloalveolar progenitors express progenitor markers, such as the 
NANOG, BMI1 and OCT4 genes, in vivo and in vitro, indicating that newborn lung 
progenitors retain characteristics typical of progenitors residing in the developing organ. 
Although dealing with a limited number of cells, these data enable the study of the 
development of the bronchiolar and alveolar epithelia. Sheep, an alternative animal model 
closer to humans than mice, are already largely used to study lung physiology and pathology. 
In this context, ovine bronchioloalveolar progenitors may represent new tools to study lung 
regeneration or new therapeutic targets. 
Methods 
Animals 
Lungs were collected from 10 young lambs either from 3 month old animals at the Corbas 
slaughterhouse (Corbas, Rhône, France), with the formal authorization for the access to the 
facility and under the supervision of Dr F. Guiguen (DVM) or from stillborn lambs from 
healthy ewes belonging to the flock providing lambs and sheep to the experimental infectious 
disease platform of the INRA Animal Health Division, Tours France; these lungs have been 
sampled by qualified staff and DVM of the core facility. None of the animals used in this 
study were engaged into an experimental protocol. 
Immediately after death, fractions of the lungs were processed as previously described [22]. 
Lungs were minced into small pieces and incubated in 10 µg/ml of DNAse I, 1 mg/ml 
protease XIV and 0.025% collagenase Ia for 2 h at 37°C, filtered through 100 µm and 40 µm 
cell strainers and centrifuged at 450 g for 10 min at 4°C. The cell pellets were collected in a 
red blood cell lysis buffer (0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) for 2 minutes, 
washed and re-suspended in 1X PBS supplemented with 4% of fetal calf serum. Cell number, 
concentration and viability were tested by trypan blue dye exclusion test on Malassez 
Chamber and were later confirmed by flow cytometry analysis upon propidium iodide (1 
mg/ml, Sigma) staining. 
Enrichment of pulmonary CD34pos cells 
Aliquots of 107 dissociated cells were labeled using an indirect CD34 labeling technique with 
magnetic beads attached to a secondary antibody. Briefly, according to the manufacturer's 
instructions (Miltenyi Biotech), the cells were incubated with a 1:200 dilution of mouse anti-
sheep CD34 antibodies (clone Eq8D11C1 kindly provided by Pr CD Porada, University of 
Nevada) for 15 min on ice, washed in a buffer containing 1X PBS, 2 mM EDTA and 0.5% 
bovine serum albumin. The mixture was then incubated for 15 min on ice with goat anti-
mouse IgG microbeads (Miltenyi France) at a 1:5 dilution in 1X PBS, 2 mM EDTA, and 
0.5% bovine serum albumin. The suspension was washed and centrifuged at 450 g for 10 min 
at 4°C. For the magnetic separation, Mini Macs separation columns (Miltenyi France) were 
rinsed with 500 µl of cold 1X PBS, 2 mM EDTA and 0.5% bovine serum albumin. The cell 
pellets were re-suspended at 107 cells per 500 µl of the same buffer and poured into the 
column reservoir. The CD34 positive (CD34pos) cells were retained onto the magnetized 
matrix of the column, whereas the non-labeled cells passed through and were collected as the 
“non-retained” fraction. The columns were rinsed three times with 500 µl of 1X PBS, 2 mM 
EDTA and 0.5% bovine serum albumin. In order to collect the CD34pos cells, the column 
were removed from the magnetic field, and were washed by gravity with 1.5 ml of 1X PBS, 2 
mM EDTA. 
Gene expression analysis of NANOG, BMI1 and OCT4 mRNAs by RT-PCR 
Total RNAs were isolated using the RNeasy Mini kit (Qiagen, France) and 200 ng of total 
RNAs were reverse transcribed into cDNA using the iScript cDNA Synthesis kit (Bio-Rad, 
France). Specific primers for ovine GAPDH, BMI1, OCT4 and NANOG were designed as 
follows (from 5' to 3'): GAPDH FOR CCACCAACTGCTTGGCCCCC, GAPDH REV 
CCTCGGCCATCACGCCACAG, SP-C FOR GCAACGCCTGGCCCTGAGT, SP-C REV 
CATAATGTAGCAGCAGGTTC, CCSP FOR GTCACCCTGACTCTCTTCTG, CCSP REV 
CAGGGCTGAAAGGTTCCAGG, CD34 FOR GATTGCACTGGTCACCTCG, CD34 REV 
CTCCACGTAATAAGGGTCTTC, OCT4 FOR CAAGAACATGTGTAAGCTGC, OCT4 
REV CGATACTCGTCCGCTTTCTC, NANOG-for 
GGCAGAAAAACAACTGGCCGAGGAA, NANOG REV 
CCCCACATGGGCAGGTTTCCAG, BMI1 FOR GCCACAACCATAATAGAATGTC and 
BMI1 REV CCCTGGAACTAATTTGTATAC. The PCR reactions were performed using 10 
ng of cDNA with the KAPA SYBR FAST kit (Cliniscience, France) as recommended. 
In vitro cell cultures of total primary cells, bronchioloalveolar progenitors, 
AEC II and club cells 
After tissue dissociation, 1.6 × 105 cells were seeded per well in 6-well plates previously 
coated with 10 mg/ml of fibronectin (Sigma), 1 µg/ml of type I collagen (Sigma) and 5 mg/ml 
of type IV collagen (Sigma) in Quantum 286 medium (PAA, Austria) supplemented with 5 
ng/ml of HGF (Hepatocyte Growth Factor; Abcys), 10ng/ml of KGF (Keratinocyte Growth 
Factor; Abcys), penicillin and streptomycin (named "complete Q286 medium") as previously 
reported [22] and maintained for 2 to 3 passages. 
To amplify the bronchioloalveolar precursors, 5 × 103 CD34pos cells were seeded per insert 
(membrane with pore size of 0,4 µm) placed in 24-well plates coated with fibronectin and 
type I and IV collagens in "complete Q286 medium" and maintained for 2 to 3 passages. 
These culture conditions with specific medium and extracellular matrix had been defined as 
the "maintenance conditions". 
In order to induce their differentiation into AECII, 5 × 103 CD34pos cells per well were 
directly seeded in 24 well plates coated with fibronectin, and type I and IV collagens with 
"complete Q286 medium" and maintained in culture up to 3 to 4 passages. These culture 
conditions had been defined as the "AECII conditions". For their differentiation into club 
cells, 5 × 103 CD34pos cells per well were seeded in 24 well plates coated with only 10 mg/ml 
of fibronectin and maintained in Quantum 286 without additional KGF and HGF (then named 
"basic Q286 medium") for 1 passage. These culture conditions had been defined as the "Club 
cell conditions". 
Phenotypic analysis 
The sorted cells were characterized for their expression of SP-C and CCSP by flow 
cytometry. After their elution from the columns, cells were rinsed in the 1X PBS and 4% fetal 
calf serum then centrifuged at 450 g 10 min at 4°C. Aliquots of 1.105 cells were stained with 
a 1:600 dilution of a rabbit anti-human proSP-C polyclonal serum (Millipore, AB3786) and a 
1:500 dilution of mouse anti-human CCSP monoclonal antibodies (Abnova H00007356-
M01). After incubation at 4°C for 1 hour, cells were stained with goat anti-rabbit IgGs 
conjugated to Alexa 488 (InVitrogen) and/or goat anti-mouse IgGs (Whole molecule) 
conjugated to R-Phycoerythrin (Sigma) for 30 minutes, at 4°C in the dark. Stained cells were 
centrifuged at 1000 g for 2 min at 4°C then fixed with 2% paraformaldehyde before flow 
cytometry quantification on a Becton Dickson FACSCalibur™ Flow cytometer and analysis 
using the CellQuest Pro software. To avoid signal overflow a color compensation of 10 to 
23% was applied. Populations of interest were gated regarding their physical properties 
(forward and size scatters) to eliminate dead cells and cell debris. Immunostaining using only 
the secondary antibody were used as controls to adjust the detection threshold for each 
measured wavelength. 
Expression of CCSP and SP-C was analyzed on fixed cultured cells or frozen lung sections. 
After fixation with 4% paraformaldehyde, cells or tissue sections were permeabilized with 
0.2% Triton X100, washed with 1X PBS and incubated 1 h, at room temperature with a 1:600 
dilution of a rabbit anti-human proSP-C polyclonal serum or a 1:500 dilution mouse anti-
human CCSP monoclonal antibodies. Cells were then washed and stained with goat anti-
rabbit IgGs conjugated to Alexa 488 or anti-mouse IgGs conjugated to R-phycoerythrin for 
30 minutes, at 4°C in the dark. The nuclei had been stained with DAPI. As negative controls, 
labeling was conducted without primary antibodies. The slides were analyzed on an 
AxioImager Microscope (Zeiss). 
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